Key result
Blood volume pulse signals combined with artificial neural networks classified no pain versus high pain with 96.6% accuracy, 100% sensitivity, and 91.6% specificity.
Why the study?
Critically ill patients often cannot self-report pain, creating an urgent need for an accurate, objective pain assessment system that does not rely on patient reporting.
Can Blood Volume Pulse (BVP) signals combined with machine learning accurately classify pain intensity levels in healthy subjects?
Can Blood Volume Pulse (BVP) signals combined with machine learning accurately classify pain intensity levels in healthy subjects?
Blood volume pulse signals combined with machine learning can provide an objective and accurate evaluation of pain levels, potentially aiding pain assessment in critically ill patients.
BVP-ML classification shows promise for objective pain assessment; leaves open validation in clinical populations.
Critically ill patients often lack cognitive or communicative functions, making it challenging to assess their pain levels using self-reporting mechanisms. There is an urgent need for an accurate system that can assess pain levels without relying on patient-reported information. Blood volume pulse (BVP) is a relatively unexplored physiological measure with the potential to assess pain levels. This study aims to develop an accurate pain intensity classification system based on BVP signals through comprehensive experimental analysis. Twenty-two healthy subjects participated in the study, in which we analyzed the classification performance of BVP signals for various pain intensities using time, frequency, and morphological features through fourteen different machine learning classifiers. Three experiments were conducted using leave-one-subject-out cross-validation to better examine the hidden signatures of BVP signals for pain level classification. The results of the experiments showed that BVP signals combined with machine learning can provide an objective and quantitative evaluation of pain levels in clinical settings. Specifically, no pain and high pain BVP signals were classified with 96.6% accuracy, 100% sensitivity, and 91.6% specificity using a combination of time, frequency, and morphological features with artificial neural networks (ANNs). The classification of no pain and low pain BVP signals yielded 83.3% accuracy using a combination of time and morphological features with the AdaBoost classifier. Finally, the multi-class experiment, which classified no pain, low pain, and high pain, achieved 69% overall accuracy using a combination of time and morphological features with ANN. In conclusion, the experimental results suggest that BVP signals combined with machine learning can offer an objective and reliable assessment of pain levels in clinical settings.
No takes yet. Share an insight, caveat, or question.
Khan et al. (2023) studied Pain assessment (n=22). Blood volume pulse (BVP) signal classification using machine learning was evaluated on Classification accuracy of no pain versus high pain BVP signals using artificial neural networks. Blood volume pulse signals combined with artificial neural networks classified no pain versus high pain with 96.6% accuracy, 100% sensitivity, and 91.6% specificity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: